Healthscope chair Paula Dwyer says the $3.6 billion private hospital, medical centre and pathology operator has a bright future and its return to the public market has been well supported by both domestic and foreign investors.
On Friday morning the company announced it successfully completed a bookbuild among institutional investors and confirmed an offer price of $2.10, which had earlier been revealed by Street Talk.
Healthscope will begin trading on at midday on Monday July 28, under the stock code HSO. At a market value of $3.6 billion, Healthscope is the biggest float since the $4.6 billion privatisation of rail freight business QR National, now known as Aurizon, in 2010.
Ms Dwyer said the company had made “significant progress” since October 2010 when a $2.7 billion buyout by private equity giants TPG and The Carlyle Group lead to its delisting from the Australian Securities Exchange.